• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE G; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT) LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE G; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT) LEAD Back to Search Results
Model Number 0185
Device Problems Failure to Capture (1081); Appropriate Term/Code Not Available (3191); High Capture Threshold (3266)
Patient Problems Erosion (1750); Unspecified Infection (1930); Heart Failure (2206); Ulcer (2274); Thrombosis/Thrombus (4440); Heart Failure/Congestive Heart Failure (4446)
Event Date 03/11/2014
Event Type  Death  
Manufacturer Narrative
This initial report was not submitted previously.As per request by the fda on january 31, 2024, the initial report has been resubmitted in an effort to release follow-up 001 from hold status.
 
Event Description
It was reported that this right ventricular (rv) lead exhibited loss of capture (loc) and high threshold measurements and was surgically abandoned.Approximately one month later this system was explanted due to infection and erosion.Approximately 2 months later a patient advocate contacted boston scientific to report that this patient had died.According to the patient advocate, this patients condition did not improve following the explant of this rv lead.Subsequently, this patient developed several co morbidities including another infection, blood clots, heart failure and internal bleeding ulcer.This patient was discharged from the hospital to a nursing home and shortly after this patient was transferred to hospice where they expired.
 
Event Description
It was reported that this right ventricular (rv) lead exhibited loss of capture (loc) and high threshold measurements and was surgically abandoned.Approximately one month later this system was explanted due to infection and erosion.Approximately 2 months later a patient advocate contacted boston scientific to report that this patient had died.According to the patient advocate, this patients condition did not improve following the explant of this rv lead.Subsequently, this patient developed several co morbidities including another infection, blood clots, heart failure and internal bleeding ulcer.This patient was discharged from the hospital to a nursing home and shortly after this patient was transferred to hospice where they expired.
 
Manufacturer Narrative
As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.This follow-up 001 report was originally submitted to the fda on june 13 2014.
 
Event Description
Boston scientific received information that this product was part of a system revision due to infection and erosion.There were no additional adverse effects reported.The product was explanted.Boston scientific received information in late-may 2014 that this patient advocate contacted boston scientific's latitude patient services to report that this patient had died in early (b)(6) 2014.According to the patient advocate, the patient's condition did not improve following the explant of this recently implanted device and right ventricular (rv) 4-site defibrillation lead.At the time of the explant procedure, two inactive leads that had been surgically capped were also explanted.Subsequently, the patient developed several co-morbidities including another infection, blood clots, heart failure and internal bleeding (ulcer).The patient was discharged from the hospital to a nursing home.Shortly thereafter, the patient was transferred to hospice where the patient died.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDOTAK RELIANCE G
Type of Device
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT) LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
CPI - DEL CARIBE
guidant puerto rico b. v.
#12, rd. #698
dorado PR 00646
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key19203751
MDR Text Key341295128
Report Number2124215-2014-06327
Device Sequence Number1
Product Code LWS
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P910073/S043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 05/23/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/29/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date08/22/2010
Device Model Number0185
Device Catalogue Number0185
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/23/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/22/2008
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Death; Life Threatening; Hospitalization;
Patient Age90 YR
Patient SexMale
-
-